{"organizations": [], "uuid": "84722d46a6084a7a65031544943172cd6a0ca085", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.pharmamedtechbi.com", "main_image": "", "site_section": "http://feeds.feedburner.com/PharmaBiotechFinancing", "section_title": "Pharma/Biotech Financing From Elsevier Business Intelligence", "url": "https://www.pharmamedtechbi.com/deals/201530744?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "country": "IL", "title": "Capnia raises $10mm in PIPE", "performance_score": 0, "site": "pharmamedtechbi.com", "participants_count": 0, "title_full": "Capnia raises $10mm in PIPE", "spam_score": 0.0, "site_type": "news", "published": "2015-10-15T02:40:00.000+03:00", "replies_count": 0, "uuid": "84722d46a6084a7a65031544943172cd6a0ca085"}, "author": "", "url": "https://www.pharmamedtechbi.com/deals/201530744?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "ord_in_thread": 0, "title": "Capnia raises $10mm in PIPE", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Capnia raises $10mm in PIPE Deal Date: Oct-01-2015 / Deal # 201530744 Executive Summary \nCapnia Inc. (technology for precision metering of gas flow) plans to raise $10mm through the sale of Series A convertible preferred shares to Sabby Management LLC, which will purchase stock in two separate transactions. Capnia will initially receive gross proceeds of $4.6mm and then will receive $5.4mm at the second closing. The preferred stock is convertible into 5.4mm common shares at a price of $1.85. Capnia will also issue five-year Series D warrants to purchase 2.7mm common shares at $2.46 per share. The warrants are non-exercisable until the earlier of shareholder approval or six months after the issuance. The proceeds will be used to expand commercial activities related to Capnia's neonatology-focused product line and to advance its pipeline.", "external_links": [], "published": "2015-10-15T02:40:00.000+03:00", "crawled": "2015-10-15T19:10:56.229+03:00", "highlightTitle": ""}